Derma Sciences Inc (NASDAQ:DSCI)

8.09
Delayed Data
As of Apr 24
 -0.31 / -3.69%
Today’s Change
7.27
Today|||52-Week Range
12.02
-13.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$208.0M

Company Description

Derma Sciences, Inc. is a medical technology company, focused on wound care. The company operates its business through three segments: Pharmaceutical Wound Care, Advanced Wound Care and Traditional Wound Care. The Pharmaceutical Wound segment offers DSC127, a novel product for the treatment of diabetic foot ulcers. The Advanced Wound Care segment includes MEDIHONEY, BIOGUARD, AMNIOEXCEL, AMNIOMATRIX, DERMAGRAN, ALGICELL AG, XTRASORB and TCC-EZ. The Traditional Wound Care segment consists of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices. It manufactures and markets adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. The company also offers skin care products, which includes barrier creams and ointments, antibacterial cleansing foams and sprays, shampoos and body washes, hand sanitizers, bath additives, body oils and moisturizers to nursing homes, hospitals, home healthcare agencies and other institutions. Derma Sciences was founded on September 10, 1984 and is headquartered in Princeton, NJ.

Contact Information

Derma Sciences, Inc.
214 Carnegie Center
Princeton New Jersey 08540
P:(609) 514-4744
Investor Relations:

Employees

Shareholders

Other institutional76.00%
Mutual fund holders22.97%
Individual stakeholders18.83%

Top Executives

Edward J. QuiltyChairman, President & Chief Executive Officer
Frederic EignerExecutive Vice President-Operations
John E. YetterChief Financial Officer & Executive Vice President
John CaminisChief Medical Officer
Robert C. ColeGroup President-Traditional Wound Care

To view my watchlist

Not a member yet?

Sign up now for a free account